Segment Information (Tables)

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Information

The following tables present our segment information for the 13 and 39 weeks ended September 30, 2023 and October 1, 2022 (in $000’s):

	Thirteen Weeks Ended				Thirty-Nine Weeks Ended
	September 30, 2023		October 1, 2022		September 30, 2023		October 1, 2022
Revenues
Biotechnology	$	—	$	—	$	—	$	—
Discontinued operations	—		8,587		3,795		28,449
Total Revenues	$	—	$	8,587	$	3,795	$	28,449
Gross profit
Biotechnology	$	—	$	—	$	—	$	—
Discontinued operations	—		1,034		(197)		4,536
Total Gross profit	$	—	$	1,034	$	(197)	$	4,536
Operating income (loss)
Biotechnology	$	(764)	$	(611)	$	(2,923)	$	(1,950)
Discontinued operations	—		(1,214)		14,158		8,016
Total Operating income (loss)	$	(764)	$	(1,825)	$	11,235	$	6,066
Depreciation and amortization
Biotechnology	$	363	$	—	$	1,090	$	—
Discontinued operations	—		77		96		347
Total Depreciation and amortization	$	363	$	77	$	1,186	$	347
Interest (income) expense, net
Biotechnology	$	(758)	$	(410)	$	(1,598)	$	(575)
Discontinued operations	—		280		181		698
Total Interest expense, net	$	(758)	$	(130)	$	(1,417)	$	123
Net income (loss) before income taxes
Biotechnology	$	(267)	$	217	$	(1,094)	$	2,609
Discontinued operations	—		(2,182)		13,976		5,518
Total Net income before income taxes	$	(267)	$	(1,965)	$	12,882	$	8,127